We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an e... Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. Show more
Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors PR Newswire WALTHAM, Mass., May 15, 2024 WALTHAM, Mass., May 15, 2024 /PRNewswire/ -- Spyre...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.78 | -2.01863354037 | 38.64 | 40.49 | 35.12 | 337264 | 37.72721678 | CS |
| 4 | 3.76 | 11.0263929619 | 34.1 | 40.49 | 31.27 | 307118 | 35.01723388 | CS |
| 12 | 16.9 | 80.6297709924 | 20.96 | 47.97 | 20.13 | 494871 | 35.84118498 | CS |
| 26 | 27.05 | 250.231267345 | 10.81 | 47.97 | 10.42 | 377035 | 31.27988469 | CS |
| 52 | 27.05 | 250.231267345 | 10.81 | 47.97 | 10.42 | 377035 | 31.27988469 | CS |
| 156 | 27.05 | 250.231267345 | 10.81 | 47.97 | 10.42 | 377035 | 31.27988469 | CS |
| 260 | 27.05 | 250.231267345 | 10.81 | 47.97 | 10.42 | 377035 | 31.27988469 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
